849532-11-2Relevant academic research and scientific papers
Sulfonylation of 1,4-Diazabicyclo[2.2.2]octane: Charge-Transfer Complex Triggered C?N Bond Cleavage
Fu, Ying,Xu, Qin-Shan,Li, Quan-Zhou,Li, Ming-Peng,Shi, Chun-Zhao,Du, Zhengyin
, p. 127 - 131 (2019/02/06)
A novel charge-transfer complex triggered sulfonylation of 1,4-diazabicyclo[2.2.2]octane (DABCO) with mild reaction conditions has been developed. The formation of a charge-transfer complex between electron-withdrawing (hetero)aryl sulfonyl chloride and D
NEW PYRIMIDINE DERIVATIVES AND THEIR USE IN THERAPY AS WELL AS THE USE OF PYRIMIDINE DERIVATIVES IN THE MANUFACTURE OF A MEDICAMENT FOR PREVENTION AND/OR TREATMENT OF ALZHEIMER’S DISEASE
-
Page/Page column 99; 51, (2008/06/13)
The present invention relates to use of compounds of formula (I) as a free base or a pharmaceutically acceptable salt, solvate or solvate of salt thereof, a process for their preparation and new intermediates used therein, as pharmaceutical ingredients fo
IMIDAZOLYL-SUBSTITUTED BENZOPHENONE COMPOUNDS
-
Page/Page column 33-34, (2008/06/13)
The compounds of formula (I) in which X, Y, R1 and R2 have the meanings as given in the description are novel effective inhibitors of the inducible nitric oxide synthase.
IMIDAZOLYL-SUBSTITUTED AZABENZOPHENONE COMPOUNDS
-
Page/Page column 36, (2010/11/26)
The compounds of formula (I) in which X, Y, R1 and R2 have the meanings as given in the description are novel effective inhibitors of the inducible nitric oxide synthase.
